EQ-5D-5L Value Set for Slovenia

Pharmacoeconomics. 2023 Nov;41(11):1515-1524. doi: 10.1007/s40273-023-01280-9. Epub 2023 Jun 21.

Abstract

Objectives: The aim of this valuation study was to produce a value set to support the use of EQ-5D-5L data in decision making in Slovenia.

Methods: The study design followed the published EuroQol research protocol, and a quota sample was defined according to age, sex, and region. Overall, 1012 adult respondents completed 10 time trade-off and seven discrete choice experiment tasks in face-to-face interviews. The Tobit model was used to analyse the composite time trade-off (cTTO) data in order to generate values for the 3125 EQ-5D-5L health states.

Results: The data showed logical consistency, with more severe states being given lower values. The greatest disutility was shown in the pain/discomfort and anxiety/depression dimensions. In the EQ-5D-5L value set, the values range from -1.09 to 1. With the exception of UA5 (unable to perform usual activities), all other levels on all health dimensions were statistically different from 0 and from each other. Compared with the existing EQ-5D-3L value set, there is a slightly lower share of 'worse than dead' states (32.1% compared with 33.7%) and the minimum value is lower.

Conclusions: Results have important implications for users of the EQ-5D-5L in Slovenia and regions. It is a robust and up-to-date value set and should be the preferred value set used in adults in Slovenia and in neighbouring countries without their own value set.

MeSH terms

  • Adult
  • Health Status*
  • Humans
  • Quality of Life*
  • Research Design
  • Slovenia
  • Surveys and Questionnaires